Drug, Biomolecule, and Vaccine Delivery

MARCH 23-25, 2027 | BOSTON, MA
View Co-Located Events

Drug, Biomolecule,
and Vaccine Delivery

Presentations in this session focus on strategies for improving the delivery of traditional small molecule drugs, proteins such as monoclonal antibodies, or genetic material (RNA, DNA). The route of administration can be systemic (e.g., IV, oral) or local (e.g., IM, topical), with the goal of enhancing delivery beyond current approaches. The delivery improvement can be in terms of timing, control, or dosing, but may also address challenges associated with biological responses to the delivery vehicle such as toxicity and immunogenicity.

Submit Early Bird Abstract for 15% Registration Discount - Due October 16

Please first review the information for authors — abstract submission guidelines.

Topics & Application Areas

Sustained/controlled release
Ligand-mediated delivery
Improved accumulation at desired site
Stimulation of specific immune pathways
Avoidance of adverse effects and toxicity
Robust resistance to disease
Other

Symposium Co-Chairs

Helen Zha

Assistant Professor

Rensselaer Polytechnic Institute

Thaiesha Wright

Assistant Professor

University of California, Los Angeles

2026 Key Speakers

Yichun Wang

Assistant Professor,

University of Notre Dame

Honggang Cui

Professor,

Johns Hopkins

Julie Champion

Professor,

Georgia Tech

Back to Top ↑ 2026 Symposium Sessions
	Tuesday March 10
1:30	Drug, Biomolecule, and Vaccine Delivery
4:00	Drug, Biomolecule, and Vaccine Delivery - Posters

2026 Symposium Program
	Tuesday March 10

1:30	Drug, Biomolecule, and Vaccine Delivery	Marriott University C
	Session chair: R. Helen Zha, Rensselaer Polytechnic Institute, & Thaiesha Wright, University of California, Los Angeles
	Molecules That Build Medicines: The Promise of Self-Assembling Therapeutics H. Cui, The Johns Hopkins University, US
	Engineering Biomimetic Materials to Empower Therapeutic Extracellular Vesicles as a Future Drug Delivery Platform Y. Wang, University of Notre Dame, US
	Engineering hexameric coiled coil fusion proteins to be anti-viral prophylactics and therapeutics L.H. Mai, J.A. Champion, Georgia Institute of Technology, US
	OcuHeal UV-400+ : Ophthalmic, UV-blocking, Anti-oxidant, Preservative-free Nanolipid Eye-drop S.P. Barman, K. Barman, S. Harris, K. Ward, Symphony Therapeutics, LLC, US
	TriNT All-Natural Curcumin Nanoparticle Encapsulation Study To Determine Pharmacokinetics, Pharmacodynamics of an All-Natural Formulation replacement to Synthetic Pain Management Medications T.N. Lucas, C.r Carrasco-Lopez, D. Deodato, C. Ameho, E. Seidel, NuShammah Pharmaceuticals, Inc., US

4:00	Drug, Biomolecule, and Vaccine Delivery - Posters	Expo Hall AB
	Nano-ERASER: A novel intracellular protein degradation platform and its application in cancer and Alzheimer’s disease therapy M. Wang and P. Xu, University of South Carolina, US